DAT1 methylation is associated with methylphenidate response on oppositional and hyperactive-impulsive symptoms in children and adolescents with ADHD

References

• American Psychiatric Association (APA). 2000. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association.
   Google Scholar
• Akutagava-Martins GC, Salatino-Oliveira A, Kieling CC, Rohde LA, Hutz MH. 2013. Genetics of attention-deficit/hyperactivity disorder: current findings and future directions. Expert Rev Neurother. 13:435–445.
   Google Scholar
• Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, et al. 2006. Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry. 15:476–495.
   Google Scholar
• Barkley RA. 2004. Adolescents with attention-deficit/hyperactivity disorder: an overview of empirically based treatments. J Psychiatr Pract. 10:39–56.
   Google Scholar
• Benarroch EE. 2013. Monoamine transporters: structure, regulation, and clinical implications. Neurology. 81:761–768.
   Google Scholar
• Bolea-Alamañac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, Heal D, Müller U, Nash J, Santosh P, et al. 2014. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol (Oxford). 28:179–203.
   Google Scholar
• Busing R, Fernandez M, Harwood M, Wei H, Garvan CW, Eyberg SM, Swanson JM. 2008. Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample. Assessment. 15:317–328.
   Google Scholar
• Cleverley K, Szatmari P, Vaillancourt T, Boyle M, Lipman E. 2012. Developmental trajectories of physical and indirect aggression from late childhood to adolescence: sex differences and outcomes in emerging adulthood. J Am Acad Child Adolesc Psychiatry. 51:1037–1051.
   Google Scholar
• Coghill D, Banaschewski T. 2009. The genetics of attention-deficit/hyperactivity disorder. Expert Rev Neurother. 9:1547–1565.
   Google Scholar
• Connor DF. 2015. Pharmacological management of pediatric patients with comorbid attention-deficit hyperactivity disorder oppositional defiant disorder. Paediatr Drugs. 17:361–371.
   Google Scholar
• Connor DF, Steeber J, McBurnett K. 2010. A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder. J Dev Behav Pediatr. 31:427–440.
   Google Scholar
• Contini V, Rovaris DL, Victor MM, Grevet EH, Rohde LA, Bau CH. 2013. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review. Eur Neuropsychopharmacol. 23:555–560.
   Google Scholar
• Dadds MR, Schollar-Root O, Lenroot R, Moul C, Hawes DJ. 2016. Epigenetic regulation of the DRD4 gene and dimensions of attention-deficit/hyperactivity disorder in children. Eur Child Adolesc Psychiatry. [Epub ahead of print 2016 Feb 20].
   Google Scholar
• El-Tarras AE, Alsulaimani AA, Awad NS, Mitwaly N, Said MM, Sabry AM. 2012. Association study between the dopamine-related candidate gene polymorphisms and ADHD among Saudi Arabia population via PCR technique. Mol Biol Rep. 39:11081–11086.
   Google Scholar
• Faraone SV, Bonvicini C, Scassellati C. 2014. Biomarkers in the diagnosis of ADHD-promising directions. Curr Psychiatry Rep. 16:497.
   Google Scholar
• Faraone SV, Mick E. 2010. Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am. 33:159–180.
   Google Scholar
• Fernandez-Jaen A, Lopez-Martin S, Albert J, Fernandez-Mayoralas DM, Fernandez-Perrone AL, de La Pena MJ, Calleja-Perez B, Rodriguez MR, Lopez-Arribas S, Munoz-Jareno N. 2015. Cortical thickness differences in the prefrontal cortex in children and adolescents with ADHD in relation to dopamine transporter (DAT1) genotype. Psychiatry Res. 233:409–417.
   Google Scholar
• Freund N, MacGillivilray HT, Thompson BS, Lukkes JL, Stanis JJ, Brenhouse HC, Andersen SL. 2014. Sex-dependent changes in ADHD-like behaviors in juvenile rats following cortical dopamine depletion. Behav Brain Res. 270:357–363.
   Google Scholar
• Froehlich TE, Epstein JN, Nick TG, Melguizo Castro MS, Stein MA, Brinkman WB, Graham AJ, Langberg JM, Kahn RS. 2011. Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 50:1129–1139.
   Google Scholar
• Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schneider J. 2008. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD. J Child Neurol. 23:981–990.
   Google Scholar
• Gold MS, Blum K, Oscar-Berman M, Braverman ER. 2014. Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children? Postgrad Med. 126:153–177.
   Google Scholar
• Hatchwell E, Greally JM. 2007. The potential role of epigenomic dysregulation in complex human disease. Trends Genet. 23:588–595.
   Google Scholar
• Hazell P. 2010. Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder. Australas Psychiatry. 18:556–559.
   Google Scholar
• Hodgkins P, Shaw M, Coghill D, Hechtman L. 2012. Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options. Eur Child Adolesc Psychiatry. 21:477–492.
   Google Scholar
• Ikegame T, Bundo M, Murata Y, Kasai K, Kato T, Iwamoto K. 2013. DNA methylation of the BDNF gene and its relevance to psychiatric disorders. J Hum Genet. 58:434–438.
   Google Scholar
• Kahn RS, Khoury J, Nichols WC, Lanphear BP. 2003. Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors. J Pediatr. 143:104–110.
   Google Scholar
• Kebir O, Joober R. 2011. Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies. Eur Arch Psychiatry Clin Neurosci. 261:583–594.
   Google Scholar
• Kolko DJ, Bukstein OG, Barron J. 1999. Methylphenidate and behaviour modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings. J Am Acad Child Adolesc Psychiatry. 38:578–586.
   Google Scholar
• Krause J. 2008. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Rev Neurother. 8:611–625.
   Google Scholar
• Lasky-Su J, Lange C, Biederman J, Tsuang M, Doyle AE, Smoller JW, Laird N, Faraone S. 2008. Family-based association analysis of a statistically derived quantitative traits for ADHD reveal an association in DRD4 with inattentive symptoms in ADHD individuals. Am J Med Genet B Neuropsychiatr Genet. 147B:100–106.
   Google Scholar
• Lavigne JV, Herzing LB, Cook EH, Lebailly SA, Gouze KR, Hopkins J, Bryant FB. 2013. Gene x environment effects of serotonin transporter, dopamine receptor D4, and monoamine oxidase A genes with contextual and parenting risk factors on symptoms of oppositional defiant disorder, anxiety, and depression in a community sample of 4-year-old children. Dev Psychopathol. 25:555–575.
   Google Scholar
• Lee SS, Lahey BB, Waldman I, Van Hulle CA, Rathouz P, Pelham WE, Loney J, Cook EH. 2007. Association of dopamine transporter genotype with disruptive behaviour disorders in an eight-year longitudinal study of children and adolescents. Am J Med Genet B Neuropsychiatr Genet. 144B:310–317.
   Google Scholar
• Lesesne CA, Visser SN, White CP. 2003. Attention-deficit/hyperactivity disorder in school-aged children: association with maternal mental health and use of health care resources. Pediatrics. 111:1232–1237.
   Google Scholar
• Levy F. 2014. Applications of pharmacogenetics in children with attention-deficit/hyperactivity disorder. Pharmgenomics Pers Med. 7:349–356.
   Google Scholar
• Li D, Sham PC, Owen MJ, He L. 2006. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet. 15:2276–2284.
   Google Scholar
• Li Z, Chang SH, Zhang LY, Gao L, Wang J. 2014. Molecular genetic studies of ADHD and its candidate genes: a review. Psychiatry Res. 219:10–24.
   Google Scholar
• Liu J, Chen J, Ehrlich S, Walton E, White T, Perrone-Bizzozero N, Bustillo J, Turner JA, Calhoun VD. 2014. Methylation patterns in whole blood correlate with symptoms in schizophrenia patients. Schizophr. Bull. 40:769–776.
   Google Scholar
• Liu J, Zhu Y, Wu YZ. 2008. Features of functional MRI in children with oppositional defiant disorder. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 33:571–575.
   Google Scholar
• Masliah E, Dumaop W, Galasko D, Desplats P. 2013. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics. 8:1030–1038.
   Google Scholar
• McGough JJ. 2005. Attention-deficit/hyperactivity disorder pharmacogenomics. Biol Psychiatry. 57:1367–1373.
   Google Scholar
• Mill J, Petronis A. 2008. Pre- and peri-natal environmental risks for attention-deficit hyperactivity disorder (ADHD): the potential role of epigenetic processes in mediating susceptibility. J Child Psychol Psychiatry. 49:1020–1030.
   Google Scholar
• Munafo MR, Yalcin B, Willis-Owen SA, Flint J. 2008. Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data. Biol Psychiatry. 63:197–206.
   Google Scholar
• Newman DP, O'Connell RG, Nathan PJ, Bellgrove MA. 2012. Dopamine transporter genotype predicts attentional asymmetry in healthy adults. Neuropsychologia. 50:2823–2829.
   Google Scholar
• Nikolaidis A, Grey JR. 2010. ADHD and the DRD4 exon III 7-repeat polymorphism: an international meta-analysis. Soc Cogn Affect Neurosci. 5:188–193.
   Google Scholar
• Pedersen KS, Bamlet WR, Oberg AL, de Andrade M, Matsumoto ME, Tang H, Thibodeau SN, Petersen GM, Wang L. 2011. Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls. PLoS One. 6:e18223.
   Google Scholar
• Perroud N, Zewdie S, Stenz L, Adouan W, Bavamian S, Prada P, Nicastro R, Hasler R, Nallet A, Piguet C, et al. 2016. Methylation fo serotonin receptor 3A in ADHD, borderline personiality, and bipolar disorders: link with severity of the disorders and childhood maltreatment. Depress Anxiety. 33:45–55.
   Google Scholar
• Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. 2015. Annual Research Review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 56:345–365.
   Google Scholar
• Polanczyk GV, Zeni C, Genro JP, Roman T, Hutz MH, Rohde LA. 2005. Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics. Pharmacogenomics. 6:225–234.
   Google Scholar
• Rader R, McCauley L, Callen EC. 2009. Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder. Am Fam Physician. 79:657–665.
   Google Scholar
• Ramdani C, Carbonnell L, Vidal F, Beranger C, Dagher A, Hasbroucq T. 2015. Dopamine precursors depletion impairs impulse control in healthy volunteers. Psychopharmacology (Berl). 232:477–487.
   Google Scholar
• Sagvolden T, Johansen EB, Aase H, Russell VA. 2005. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci. 28:397–419.
   Google Scholar
• Sanchez-Mora C, Ribases M, Mulas F, Soutullo C, Sans A, Pamias M, Casas M, Ramos-Quiroga JA. 2012. Genetic bases of attention deficit hyperactivity disorder. Rev Neurol. 55:609–618.
   Google Scholar
• Sapienza C, Lee J, Powell J, Erinle O, Yafai F, Reichert J, Sira ES, Madaio M. 2011. DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. Epigenetics. 6:20–28.
   Google Scholar
• Schuch V, Utsumi DA, Costa TV, Kulikowski LD, Muszkat M. 2015. Attention deficit hyperactivity disorder in the light of the epigenetic paradigm. Front Psychiatry. 6:126.
   Google Scholar
• Sebastian A, Jung P, Krause-Utz A, Lieb K, Schmahl C, Tuscher O. 2014. Frontal dysfunctions of impulse control - a systematic review in borderline personality disorder and attention-deficit/hyperactivity disorder. Front Hum Neurosci. 8:698.
   Google Scholar
• Serra-Pinheiro MA, Mattos P, Souza I, Pastura G, Gomes F. 2004a. The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit/hyperactivity disorder. Arq Neuropsiquiatr. 62:399–402.
   Google Scholar
• Serra-Pinheiro MA, Schmitz M, Mattos P, Souza I. 2004b. Oppositional defiant disorder: a review of neurobiological and environmental correlates, comorbidities, treatment and prognosis. Rev Bras Psiquiatr. 26:273–276.
   Google Scholar
• Sokolova E, Hoogman M, Groot P, Claassen T, Vasquez AA, Buitelaar JK, Franke B, Heskes T. 2015. Causal discovery in an adult ADHD data set suggests indirect link between DAT1 genetic variants and striatal brain activation during reward processing. Am J Med Genet B Neuropsychiatr Genet. 168B:508–515.
   Google Scholar
• Sonuga-Barke EJ. 2005. Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry. 57:1231–1238.
   Google Scholar
• Sonuga-Barke EJ, Fairchild G. 2012. Neuroeconomics of attention-deficit/hyperactivity disorder: differential influences of medial, dorsal, and ventral prefrontal brain networks on suboptimal decision making? Biol Psychiatry. 72:126–133.
   Google Scholar
• Spencer T, Wilens T, Harding M, O'Donnell D, Griffin S. 1996. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 35:409–432.
   Google Scholar
• Stringaris A, Goodman R. 2009. Longitudinal outcome of youth oppositionality: irritable, headstrong, and hurtful behaviors have distinctive predictions. J Am Acad Child Adolesc Psychiatry. 48:404–412.
   Google Scholar
• Tao GT, Zheng Y, Song WC. 2008. Child and adolescnt psychiatry. 2nd ed. Nanjing: Phoenix Publishing & Media (Jiangsu Science and Technology Press).
   Google Scholar
• Thissen AJ, Bralten J, Rommelse NN, Arias-Vasquez A, Greven CU, Heslenfeld D, Luman M, Oosterlaan J, Hoekstra PJ, Hartman C, et al. 2015. The role of age in association analyses of ADHD and related neurocognitive functioning: a proof of concept for dopaminergic and serotonergic genes. Am J Med Genet B Neuropsychiatr Genet. 168B:471–479.
   Google Scholar
• Torres GE, Gainetdinov RR, Caron MG. 2003. Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci. 4:13–25.
   Google Scholar
• Turic D, Swanson J, Sonuga-Barke E. 2010. DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics. Pharmgenomics Pers Med. 3:61–78.
   Google Scholar
• UCSC. 2012. Genome Bioinformatics [Internet]. Santa Cruz: UCSC Genome Informatics Group; [cited 2012 Aug 22]. Available from: http://www.genome.ucsc.edu/.
   Google Scholar
• van Mil NH, Steegers-Theunissen RP, Bouwland-Both MI, Verbiest MM, Rijlaarsdam J, Hofman A, Steegers EA, Heijmans BT, Jaddoe VW, Verhulst FC, et al. 2014. DNA methylation profiles at birth and child ADHD symptoms. J Psychiatr Res. 49:51–59.
   Google Scholar
• Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O. 1991. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 350:610–614.
   Google Scholar
• Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, et al. 2007. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 64:932–940.
   Google Scholar
• Wang Y, Zheng Y, Du Y, Song DH, Shin YJ, Cho SC, Kim BN, Ahn DH, Marquez-Caraveo ME, Gao H, et al. 2007. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Aust NZ J Psychiatry. 41:222–230.
   Google Scholar
• Xu Y, Chen XT, Luo M, Tang Y, Zhang G, Wu D, Yang B, Ruan DY, Wang HL. 2015. Multiple epigenetic factors predict the attention deficit/hyperactivity disorder among the Chinese Han children. J Psychiatr Res. 64:40–50.
   Google Scholar
• Yang L, Wang YF, Li J, Faraone SV. 2004. Association of norepinephrine transporter gene with methylphenidate response. J Am Acad Child Adolesc Psychiatry. 43:1154–1158.
   Google Scholar
• Yang L, Wang YF, Qian QJ, GU BM. 2001. Primary exploration of the clinical subtypes of attention deficit hyperactivity disorder in Chinese children. Chinese J Psychiatry. 34:204–207.
   Google Scholar